Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients

Allende, Ricardo, Webb, John G., Munoz-Garcia, Antonio J., de Jaegere, Peter, Tamburino, Corrado, Dager, Antonio E., Cheema, Asim, Serra, Vicenç, Amat-Santos, Ignacio, Velianou, James L., Barbanti, Marco, Dvir, Danny, Alonso-Briales, Juan H., Nuis, Rutger-Jan, Faqiri, Elhamula, Imme, Sebastiano, Benitez, Luis Miguel, Cucalon, Angela Maria, Al Lawati, Hatim, Garcia del Blanco, Bruno, Lopez, Javier, Natarajan, Madhu K., DeLarochellière, Robert, Urena, Marina, Ribeiro, Henrique B., Dumont, Eric, Nombela-Franco, Luis, Rodés-Cabau, Josep · 2014 · European Heart Journal

Abstract

AIM: The aim of this study was to determine the effects of advanced chronic kidney disease (CKD) on early and late outcomes after transcatheter aortic valve implantation (TAVI), and to evaluate the predictive factors of poorer outcomes in such patients. METHODS AND RESULTS: This was a multicentre study including a total of 2075 consecutive patients who had undergone TAVI. Patients were grouped according the estimated glomerular filtration rate as follows: CKD stage 1-2 (≥60 mL/min/1.73 m(2); n = 950), stage 3 (30-59 mL/min/1.73 m(2); n = 924), stage 4 (15-29 mL/min/1.73 m(2); n = 134) and stage 5 (<15 mL/min/1.73 m² or dialysis; n = 67). Clinical outcomes were evaluated at 30-days and at follow-up (median of 15 [6-29] months) and defined according to the VARC criteria. Advanced CKD (stage 4-5) was an independent predictor of 30-day major/life-threatening bleeding (P = 0.001) and mortality (P = 0.027), and late overall, cardiovascular and non-cardiovascular mortality (P < 0.01 for all). Pre-existing atrial fibrillation (HR: 2.29, 95% CI: 1.47-3.58, P = 0.001) and dialysis therapy (HR: 1.86, 95% CI: 1.17-2.97, P = 0.009) were the predictors of mortality in advanced CKD patients, with a mortality rate as high as 71% at 1-year follow-up in those patients with these 2 factors. Advanced CKD patients who had survived at 1-year follow-up exhibited both a significant improvement in NYHA class (P < 0.001) and no deterioration in valve hemodynamics (P = NS for changes in mean gradient and valve area over time). CONCLUSIONS: Advanced CKD was associated with a higher rate of early and late mortality and bleeding events following TAVI, with AF and dialysis therapy determining a higher risk in these patients. The mortality rate of patients with both factors was unacceptably high and this should be taken into account in the clinical decision-making process in this challenging group of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu175

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 161

Metadata

Authors
Allende, R., Webb, J. G., Munoz-Garcia, A. J., de Jaegere, P., Tamburino, C., Dager, A. E., Cheema, A., Serra, V., Amat-Santos, I., Velianou, J. L., Barbanti, M., Dvir, D., Alonso-Briales, J. H., Nuis, R.-J., Faqiri, E., Imme, S., Benitez, L. M., Cucalon, A. M., Al Lawati, H., Garcia del Blanco, B., Lopez, J., Natarajan, M. K., DeLarochellière, R., Urena, M., Ribeiro, H. B., Dumont, E., Nombela-Franco, L., & Rodés-Cabau, J.
Venue
European Heart Journal
Published
2014-05-05
Volume
35
Issue
38
Pages
2685-2696
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2067130633
Cited by
161
References
4
FWCI
9.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. https://app.cochat.ai/papers/10.1093/eurheartj/ehu175
The paper
Allende, R., Webb, J. G., Munoz-Garcia, A. J., de Jaegere, P., Tamburino, C., Dager, A. E., Cheema, A., Serra, V., Amat-Santos, I., Velianou, J. L., Barbanti, M., Dvir, D., Alonso-Briales, J. H., Nuis, R.-J., Faqiri, E., Imme, S., Benitez, L. M., Cucalon, A. M., Al Lawati, H., . . . Rodés-Cabau, J. (2014). Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.